In order to increase their product portfolio and gain a competitive edge in the market, key players in the space are concentrating on different business strategies like product launches. For instance, the pharmaceutical company Fidia Pharma USA Inc. introduced the NuDYN product, a regenerative medicine, in March 2019. This is the business's offering in the first category of regenerative medicine.
Major market players are concentrating on a range of business strategies, including capacity growth, in order to improve their global Regenerative Medicine Market presence. For instance, the regenerative medicine company CollPlant opened a new headquarters and R&D facility in Israel in May 2019. The newly constructed R&D centre will help COllPlant develop its product pipeline, including Biolinks, which enables 3D bioprinting of organs and tissues.
Read More:
https://knackersblogger.blogspot.com/2022/11/regenerative-medicine-market-global.html
Comments
0 comment